AccessHope Fortifies Leadership to Scale National Cancer Care Access

DUARTE, Calif. – April 09, 2026 – AccessHope, a company aiming to democratize access to high-level cancer expertise, has significantly expanded its leadership team, signaling an aggressive strategy to accelerate its national growth and solidify its position in the competitive employer benefits market. The appointments bring in a cohort of seasoned executives from prominent digital health and insurance firms, arming the company with proven experience in scaling commercial operations and navigating the complex healthcare landscape.

The strategic hires are poised to bolster the company’s efforts to connect more patients with its network of subspecialists from National Cancer Institute-designated Comprehensive Cancer Centers (NCI-CCCs). This move comes as employers and health plans grapple with the ever-increasing clinical complexity and financial burden of cancer, creating a fervent demand for solutions that deliver both improved patient outcomes and measurable value.

A Strategic Infusion of Proven Growth Leaders

The series of leadership appointments is notable for the depth and relevance of the new executives' backgrounds. The team now includes several individuals with experience at Ginger (now Headspace Health), a digital mental health company known for its rapid scaling and successful market penetration.

Peter Bridges, who continues in an expanded role as Chief Strategy and Chief Commercial Officer, brings a history of dramatic growth, having previously overseen an 18x revenue increase at Ginger. His experience at health consultancies like Aon and Willis Towers Watson provides a deep understanding of the employer and payer perspective.

Joining the team is Jerrod Helms as the new Chief Revenue Officer. Helms has over two decades of experience growing commercial teams at both industry giants like Humana and digital health disruptors such as DarioHealth and Ginger. His expertise in aligning innovative clinical models with the purchasing and reimbursement practices of large enterprises is a direct asset for AccessHope's expansion goals.

Nicola Kamath takes on the dual role of Chief Marketing and Chief Client Success Officer, tasked with integrating these functions to drive revenue. Her nearly twenty-year career includes leadership positions at a string of successful health-tech firms, including Castlight Health, Phreesia, and Ginger, where she honed skills in aligning brand strategy with client value. The new structure also includes Matt Anderson as Vice President of Employer and Channel Sales and Lee Byrne as Head of Commercial and Go-to-Market Operations, both bringing extensive experience from the health and technology sectors. This concentration of talent, particularly from companies that have successfully scaled digital health solutions for the enterprise market, suggests a deliberate and strategic move to replicate that success in the specialized field of oncology.

Targeting the High-Stakes Cancer Care Challenge

The leadership overhaul is a direct response to a pressing market need. Cancer remains one of the most challenging and expensive areas for the U.S. healthcare system. For employers and health plans, it represents not only a significant cost driver but also a profound challenge in ensuring their members receive appropriate, evidence-based care in a timely manner. The landscape of oncology is evolving at a breakneck pace, with new diagnostics, targeted therapies, and clinical trials making it nearly impossible for non-specialists to keep up.

AccessHope CEO Brad Kreik highlighted this challenge in the company's announcement. "Cancer remains one of the most complex and costly challenges facing employers and health plans, and meeting that challenge requires deep expertise, disciplined execution, and a commitment to accountable value," he stated. "With our latest appointments, AccessHope is even better positioned to scale nationally, strengthen our partnerships, and ensure more people receive the right cancer expertise at the right time."

Companies are increasingly seeking benefits solutions that can provide a clear return on investment, not just through potential cost savings but also through improved employee health, reduced productivity loss, and enhanced employee satisfaction. By offering a direct line to elite cancer specialists, AccessHope aims to optimize treatment plans from the outset, potentially avoiding costly missteps and improving long-term outcomes.

Democratizing Elite Oncology Expertise

At the core of AccessHope's model is its partnership with world-renowned NCI-designated Comprehensive Cancer Centers. The company, which was originally spun out of the NCI-CCC City of Hope, acts as a technological and logistical bridge, connecting a patient's local oncologist with subspecialists who have deep expertise in specific and rare forms of cancer. This remote collaboration model is designed to overcome the geographical and socioeconomic barriers that often prevent patients from accessing top-tier care.

Through case reviews, second opinions, and assistance with identifying relevant clinical trials, the service aims to ensure every patient's treatment plan is aligned with the latest medical evidence. Research has consistently shown that expert second opinions in oncology can lead to significant changes in diagnosis or treatment recommendations, which can improve survival rates and prevent patients from undergoing unnecessary or ineffective procedures.

By embedding this service within an employer or health plan benefit, AccessHope makes this level of expertise automatically available to members, removing the burden on patients to seek it out and finance it themselves. This approach directly addresses the issue of health equity, aiming to standardize the quality of cancer care recommendations for all members, regardless of their location or personal resources.

Fortifying the Go-to-Market Machine

With this newly fortified leadership team, AccessHope is clearly building a powerful commercial engine designed for rapid scale. The specific roles—focusing on revenue, client success, and operational efficiency—reflect a mature strategy to not only win new business but also to retain and expand relationships with its more than 800 existing client organizations, which include over 80 Fortune 500 companies.

Lee Byrne's role as Head of Commercial and Go-to-Market Operations is particularly indicative of this focus. His mandate to strengthen forecasting, pipeline management, and sales process optimization is critical for creating a predictable and scalable growth model. This operational discipline is what separates fast-growing companies from those that falter under their own expansion.

As AccessHope pushes for a larger national footprint, the collective experience of its new leadership in digital health commercialization will be a key determinant of its success. The company is betting that by combining its unique clinical model with a world-class commercial team, it can effectively address the urgent demand for better cancer care management and establish itself as the indispensable partner for employers and health plans across the country.